Skip to main content
. 2021 Feb 24;14:1239–1248. doi: 10.2147/OTT.S294253

Figure 2.

Figure 2

Combination of AEPS and PD1 antibody prolonged survival in colorectal cancer–xenograft mice. CT26 cells were inoculated to establish the colorectal cancer–xenograft mouse model, 5 mL/kg•day AEPS was given orally and 10 mg/kg•week anti-PD1 injected intravenously separately or combined until the mouse was dead. Their survival was recorded individually.